Follow Adial Pharmaceuticals, Inc.. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
8 Stories in coverage 0 Programs 0 Registered trials 8-K Nov 12 Latest SEC filing Nov 16 Latest story
Timeline 8 Pipeline 0 Trials 0
All8 Regulatory1 Filings and people7
Details
Headquarters Charlottesville, VA Incorporated Delaware Industry Pharmaceutical Preparations Formerly Adial Pharmaceuticals, L.L.C. (to 2017); ADial Pharmaceuticals, L.L.C. (to 2017) Also known as Adial Pharmaceuticals, L.L.C., ADIL How the company describes itself Adial Pharmaceuticals develops AD04, a small molecule therapeutic for alcohol use disorder in genetically defined patient subpopulations, currently in Phase 3 clinical development. The company is based in the United States. source